Call Options

8 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 09, 2024

BUY
$57.6 - $68.62 $34.4 Million - $41 Million
597,100 New
597,100 $40.9 Million
Q1 2022

May 11, 2022

SELL
$40.9 - $45.1 $11.6 Million - $12.8 Million
-283,300 Reduced 87.33%
41,100 $1.82 Million
Q4 2021

Feb 10, 2022

BUY
$38.07 - $44.87 $9.76 Million - $11.5 Million
256,300 Added 376.36%
324,400 $13.8 Million
Q4 2020

Feb 12, 2021

SELL
$33.15 - $41.97 $2.29 Million - $2.9 Million
-69,000 Reduced 50.33%
68,100 $2.45 Million
Q3 2020

Nov 13, 2020

SELL
$34.44 - $42.23 $1.32 Million - $1.62 Million
-38,300 Reduced 21.84%
137,100 $5.24 Million
Q2 2020

Aug 12, 2020

BUY
$30.19 - $39.11 $5.06 Million - $6.56 Million
167,700 Added 2177.92%
175,400 $6.16 Million
Q2 2019

Aug 12, 2019

SELL
$34.91 - $42.98 $415,428 - $511,461
-11,900 Reduced 60.71%
7,700 $331,000
Q1 2019

May 10, 2019

BUY
$32.91 - $40.75 $645,035 - $798,700
19,600 New
19,600 $752,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $121B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Twin Tree Management, LP Portfolio

Follow Twin Tree Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Twin Tree Management, LP with notifications on news.